Pharmaceuticals

Biguanides Market Research: Growth Projections and Trends 2030

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the biguanides market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Biguanides Market be in 2030 compared with 2026?

The biguanides market size has shown consistent expansion in recent years. It is projected to increase from $5.11 billion in 2025 to $5.28 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 3.4%. The growth observed in the past can be ascribed to the rising prevalence of type 2 diabetes, enhanced awareness of metabolic disorders, the expanding availability of generic biguanides, the adoption of oral antidiabetic medications, and advancements in liver-targeted therapies.

The biguanides market is anticipated to exhibit sustained expansion over the coming years, with its size projected to reach $5.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 3.1%. This growth during the forecast period is primarily driven by factors such as the increasing demand for personalized medicine, the broader adoption of telemedicine for diabetes care, a rising incidence of PCOS, the continued development of combination therapies, and government initiatives promoting chronic disease management. Key trends expected in this period include personalized diabetes management solutions, the evolution of combination therapy, expanded indications beyond type 2 diabetes, the integration of home healthcare and remote patient monitoring, and the emergence of cost-effective generic biguanides.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15735&type=smp

What Drivers Are Guiding Growth Patterns In The Biguanides Market?

The biguanides market is poised for expansion due to the escalating incidence of diabetes. Diabetes is a persistent metabolic ailment identified by elevated blood glucose levels, caused by either inadequate insulin generation or impaired insulin functionality. This increase in diabetes cases is fueled by evolving lifestyle patterns, an aging global population, and heightened diagnostic understanding. The biguanides market supports diabetes treatment by enhancing insulin sensitivity, curtailing glucose production in the liver, and assisting in the reduction of blood sugar levels for individuals with type 2 diabetes. For instance, in March 2024, data from the Office for Health Improvement & Disparities (OHID), a UK-based government department, indicated that from March 2022 to March 2023, the percentage of people with type 1 diabetes receiving all eight recommended care processes rose by 22%, whereas for type 2 diabetes, it increased by 21%, and the proportion reaching target HbA1c levels reached an all-time high of 37.9%. Consequently, the growing prevalence of diabetes is a significant force driving the biguanides market’s growth.

Which Segments Are Driving Activity In The Biguanides Market?

The biguanides market covered in this report is segmented –

1) By Type: Metformin, Phenformin, Other Types

2) By Dosage Form: Tablets, Oral Solutions

3) By Formulation: Immediate Release, Extended Release

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Metformin: Immediate-Release Metformin, Extended-Release Metformin

2) By Phenformin: Phenformin Hydrochloride

3) By Other Types: Buformin, Metformin Combinations

What Trends Are Projected To Support The Growth Of The Biguanides Market?

Major companies in the biguanide market are concentrating on developing advanced solutions, such as extended-release biguanide formulations, to enhance patient compliance, improve glycemic control, and minimize gastrointestinal side effects. Extended-release biguanide formulations are medications designed to gradually release their active component over time, thereby maintaining stable blood concentrations, improving tolerability, and supporting better long-term adherence for individuals managing diabetes. For instance, in August 2023, Dr. Reddy’s Laboratories, an India-based biotechnology company, launched saxagliptin and metformin hydrochloride extended-release tablets. This product is a USFDA-approved generic version of KOMBIGLYZE XR, which combines saxagliptin, a DPP-4 inhibitor, with metformin, a biguanide, offering adults with type 2 diabetes mellitus an effective once-daily treatment option that aids in improved glycemic control when used alongside diet and exercise, while also enhancing adherence through its extended-release design.

Which Leading Companies Dominate The Biguanides Market Share?

Major companies operating in the biguanides market are Pfizer Inc., Sanofi-Aventis LLC, Viatris Inc., Aurobindo Pharma Ltd., Cipla Ltd, Dr. Reddy’s Laboratories, Lupin Limited, Zydus Lifesciences Limited, Torrent Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Apotex Inc, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Mylan Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Panacea Biotech Ltd., Wanbury Ltd, USV Private Limited, Abbott Laboratories

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report

How Does The Biguanides Market Perform Across Major Global Regions?

Asia-Pacific was the largest region in the biguanides market in 2025. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biguanides Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15735&type=smp

Browse Through More Reports Similar to the Global Biguanides Market 2026, By The Business Research Company

Biguanides Market Report 2026

https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report

Artichokes Market Report 2026

https://www.thebusinessresearchcompany.com/report/artichokes-global-market-report

Mushroom Market 2026

https://www.thebusinessresearchcompany.com/report/mushroom-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795